documents: FDA-2025-P-2611-0002

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2025-P-2611-0002 FDA FDA-2025-P-2611 Acknowledgement Letter from FDA DMB to Apozeal Pharmaceuticals Inc. Other Acknowledgement Letter/Receipt 2025-07-24T04:00:00Z 2025 7 2025-07-24T04:00:00Z   2025-07-24T20:59:56Z   0 0 09000064b8e9a0ce

Links from other tables